[125I]neurotensin (human, mouse, rat) [7721]
[125I]neurotensin (human, mouse, rat)
| SMILES |
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)O |
| InChIKey |
PCJGZPGTCUMMOT-ISULXFBGSA-N |
| Sequence |
XLYENKPRRPYIL |
| HELM |
PEPTIDE1{[Glp].L.Y.E.N.K.P.R.R.P.Y.I.L}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
21 |
| Hydrogen bond donors |
21 |
| Rotatable bonds |
50 |
| Log P |
-3.809 |
| Molecular weight (Da) |
1671.9 |
| Stereochemistry info |
partial |
| Radioactive |
125I |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
[125I]neurotensin (human, mouse, rat)
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.